These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1209053)

  • 1. [Treatment of parkinsonian syndrome with Ro 8-0576].
    Bernales JV; Mere AF; Portillo R
    Rev Neuropsiquiatr; 1975 Jun; 38(2):65-73. PubMed ID: 1209053
    [No Abstract]   [Full Text] [Related]  

  • 2. [A year of treatment with carbidopa and levodopa in Parkinsonian patients].
    Martínez-Lage JM; Marti-Massó JF; Delgado G; Carreray N; Del Amo F
    Rev Clin Esp; 1974 Sep; 134(6):535-42. PubMed ID: 4450036
    [No Abstract]   [Full Text] [Related]  

  • 3. [Aspects of long-term treatment with levodopa alone and levodopa combined with dopa decarboxylase inhibitors].
    Cinca I; Serbănescu A; Tudorache B
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1982; 27(4):261-70. PubMed ID: 6222452
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of efficacy of lisuride hydrogen maleate with increased doses of levodopa in parkinsonian patients.
    Rabey JM; Treves T; Streifler M; Korczyn AD
    Adv Neurol; 1987; 45():569-72. PubMed ID: 3825734
    [No Abstract]   [Full Text] [Related]  

  • 5. [Neuroleptic malignant-like syndrome following levodopa withdrawal].
    Rascol O; Salachas F; Montastruc JL
    Rev Neurol (Paris); 1990; 146(3):215-8. PubMed ID: 2184486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The treatment of Parkinson disease using the combination bromocriptine and levodopa].
    Dufresne JJ
    Rev Med Suisse Romande; 1990 Jun; 110(6):559-64. PubMed ID: 2367793
    [No Abstract]   [Full Text] [Related]  

  • 7. [Early or late onset of L-dopa treatment in Parkinson disease?].
    von Kummer R; Schneevoigt K
    Nervenarzt; 1986 Nov; 57(11):634-9. PubMed ID: 3808131
    [No Abstract]   [Full Text] [Related]  

  • 8. [Our experience in the treatment of Parkinson's disease with L-dopa plus RO 4-4602 combination].
    Campanella G; Pennetta R
    Acta Neurol (Napoli); 1974; 29(3):252-63. PubMed ID: 4417098
    [No Abstract]   [Full Text] [Related]  

  • 9. [Oral lisuride in Parkinson's disease].
    Obeso JA; Luquin MR; Martínez Lage JM
    Med Clin (Barc); 1985 Sep; 85(8):307-12. PubMed ID: 4068822
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pergolide: a useful agonist for the treatment of Parkinson disease].
    Bonnet AM; Houeto JL
    Rev Neurol (Paris); 2002 Jul; 158(6-7):744-5. PubMed ID: 12486908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current controversies: levodopa in the treatment of Parkinson's disease.
    Sharma JC; Vassallo M; Ross IN
    Mov Disord; 2005 May; 20(5):642-3; author reply 643-4. PubMed ID: 15732129
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of Parkinson's disease in Spain.
    Grandas F; Kulisevsky J
    Mov Disord; 2003 Jan; 18(1):87-9. PubMed ID: 12518304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease and long-term levodopa therapy.
    Bergmann KJ; Mendoza MR; Yahr MD
    Adv Neurol; 1987; 45():463-7. PubMed ID: 3103389
    [No Abstract]   [Full Text] [Related]  

  • 14. Blink reflex in Parkinson's disease with levodopa-induced dyskinesia.
    Iriarte LM; Chacon J; Madrazo J; Chaparro P
    Funct Neurol; 1989; 4(3):257-61. PubMed ID: 2792861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulatory effect of clozapine on levodopa response in Parkinson's disease: a preliminary study.
    Arevalo GJ; Gershanik OS
    Mov Disord; 1993 Jul; 8(3):349-54. PubMed ID: 8341300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient levodopa withdrawal in Parkinson's disease.
    Maesner JE
    Clin Pharm; 1987 Jan; 6(1):22. PubMed ID: 3816104
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparative study of bromocriptine and levodopa in Parkinson's disease.
    Duvoisin RC; Mendoza MM; Yahr MD
    Adv Biochem Psychopharmacol; 1980; 23():271-5. PubMed ID: 7395618
    [No Abstract]   [Full Text] [Related]  

  • 18. Familial levodopa-responsive parkinsonian-pyramidal syndrome.
    Nisipeanu P; Kuritzky A; Korczyn AD
    Mov Disord; 1994 Nov; 9(6):673-5. PubMed ID: 7845409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of chronic levodopa therapy in Parkinson's disease.
    Battistin L; Bracco F; Saladini M
    J Neural Transm Suppl; 1986; 22():201-7. PubMed ID: 3465871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for motor response complications in L-dopa-treated parkinsonian patients.
    Peppe A; Dambrosia JM; Chase TN
    Adv Neurol; 1993; 60():698-702. PubMed ID: 8420213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.